| Pharmaceutical active ingredients: |
| Hydrocodone BitartratePhenylephrine Hydrochloride |
| Available forms, composition and doses of Novahistine DH: |
| Syrup; Oral; Hydrocodone Bitartrate 1.7 mg; Phenylephrine Hydrochloride 10 mg / 5 ml |
| Novahistine DH medical category: |
| Human:Antitussives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA53 - Phenylephrine, combinationsR05DA03 - HydrocodoneR05DA20 - Opium alkaloids and derivatives, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisGlaxoSmithKline |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Caldomine DH Enfant | Hydrocodone Bitartrate; Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Ratiopharm |
| Tussaminic DH Forte | Hydrocodone Bitartrate; Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis |
| Tussaminic DH Pediatric | Hydrocodone Bitartrate; Pheniramine Maleate; Phenylpropanolamine Hydrochloride; Pyrilamine Maleate | Novartis |
| Coristine-DH | Hydrocodone Bitartrate; Phenylephrine Hydrochloride | Ratiopharm; Technilab Pharma |
| Novahistex DH | Hydrocodone Bitartrate; Phenylephrine Hydrochloride | Sanofi-Aventis |
| Ratio-Coristex-DH | Hydrocodone Bitartrate; Phenylephrine Hydrochloride | Ratiopharm |
| Codamine | Hydrocodone Bitartrate; Phenylpropanolamine Hydrochloride | Alpharma |
| Hycomine | Hydrocodone Bitartrate; Phenylpropanolamine Hydrochloride | Endo Pharmaceuticals |
| Hycomine Pediatric | Hydrocodone Bitartrate; Phenylpropanolamine Hydrochloride | Endo Pharmaceuticals |
| Rezira | Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride | Cypress Pharmaceutical; Hawthorn Pharmaceuticals |